• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自组装肽-多金属氧酸盐杂化纳米球:二合一增强了对与阿尔茨海默病相关的淀粉样β肽聚集的靶向抑制作用。

Self-assembled peptide-polyoxometalate hybrid nanospheres: two in one enhances targeted inhibition of amyloid β-peptide aggregation associated with Alzheimer's disease.

机构信息

Laboratory of Chemical Biology, Division of Biological Inorganic Chemistry, State Key Laboratory of Rare Earth, Resource Utilization, Changchun Institute of Applied Chemistry, Graduate School of the Chinese Academy of Sciences, Chinese Academy of Sciences, Changchun, Jilin 130022, China, Fax: 86-431-85262625.

出版信息

Small. 2013 Oct 25;9(20):3455-61. doi: 10.1002/smll.201202612. Epub 2013 May 6.

DOI:10.1002/smll.201202612
PMID:23650245
Abstract

Amyloid fibril formation is a critical step in Alzheimer's disease (AD) pathogenesis. Inhibition of Aβ aggregation has shown promising against AD and has been used in clinic trials. Here, a novel strategy is reported for the self-assembly of polyoxometalate-peptide (POM@P) hybrid particles as bifunctional Aβ inhibitors. The two-in-one bifunctional POM@P nanoparticles show an enhanced inhibition effect on amyloid aggregation in mice cerebrospinal fluid. Incorporating a clinically used Aβ fibril-staining dye, congo red (CR), into the hybrid colloidal spheres, the nanoparticles can also act as an effective fluorescent probe to monitor the inhibition process of POM@P via CR fluorescence change in real time. It is believed that such flexible organic-inorganic hybrid systems may prompt the design of new multifunctional materials for AD treatment.

摘要

淀粉样纤维形成是阿尔茨海默病(AD)发病机制中的关键步骤。抑制 Aβ聚集已显示出对抗 AD 的前景,并已在临床试验中使用。在这里,报道了一种将多金属氧酸盐-肽(POM@P)杂化颗粒自组装为双功能 Aβ抑制剂的新策略。这种双功能 POM@P 纳米粒子在增强对小鼠脑脊髓液中淀粉样聚集的抑制作用方面显示出优异的性能。将临床上使用的 Aβ纤维染色染料刚果红(CR)掺入杂化胶体球中,纳米粒子还可以作为有效的荧光探针,通过 CR 荧光变化实时监测 POM@P 的抑制过程。相信这种灵活的有机-无机杂化体系可能会促使设计用于 AD 治疗的新型多功能材料。

相似文献

1
Self-assembled peptide-polyoxometalate hybrid nanospheres: two in one enhances targeted inhibition of amyloid β-peptide aggregation associated with Alzheimer's disease.自组装肽-多金属氧酸盐杂化纳米球:二合一增强了对与阿尔茨海默病相关的淀粉样β肽聚集的靶向抑制作用。
Small. 2013 Oct 25;9(20):3455-61. doi: 10.1002/smll.201202612. Epub 2013 May 6.
2
Gold-nanoparticle-based multifunctional amyloid-β inhibitor against Alzheimer's disease.基于金纳米颗粒的抗阿尔茨海默病多功能淀粉样β蛋白抑制剂
Chemistry. 2015 Jan 7;21(2):829-35. doi: 10.1002/chem.201404562. Epub 2014 Nov 5.
3
Mo polyoxometalate nanoclusters capable of inhibiting the aggregation of Aβ-peptide associated with Alzheimer's disease.钼多金属氧酸盐纳米簇能够抑制与阿尔茨海默病相关的 Aβ-肽的聚集。
Nanoscale. 2014 Jun 21;6(12):6886-97. doi: 10.1039/c3nr05906e.
4
Chiral Metallo-Supramolecular Complex Directed Enantioselective Self-Assembly of β-Sheet Breaker Peptide for Amyloid Inhibition.手性金属超分子配合物导向β-折叠破坏肽的对映选择性自组装用于抑制淀粉样蛋白。
Small. 2015 Sep;11(36):4651-5. doi: 10.1002/smll.201501329. Epub 2015 Jul 1.
5
Transition-metal-substituted polyoxometalate derivatives as functional anti-amyloid agents for Alzheimer's disease.过渡金属取代的多金属氧酸盐衍生物作为阿尔茨海默病的功能型抗淀粉样蛋白药物。
Nat Commun. 2014 Mar 4;5:3422. doi: 10.1038/ncomms4422.
6
Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization.靶向阿尔茨海默病中的神经毒性物质:β-淀粉样蛋白寡聚化抑制剂
FASEB J. 2004 Sep;18(12):1366-72. doi: 10.1096/fj.04-1764com.
7
NMR reveals two-step association of Congo Red to amyloid β in low-molecular-weight aggregates.NMR 揭示刚果红与低分子量聚集物中的淀粉样 β 之间的两步结合。
J Phys Chem B. 2010 Dec 9;114(48):16003-10. doi: 10.1021/jp108035y. Epub 2010 Nov 15.
8
Randomization of amyloid-β-peptide(1-42) conformation by sulfonated and sulfated nanoparticles reduces aggregation and cytotoxicity.通过磺化和硫酸化纳米粒子使淀粉样β肽(1-42)构象随机化可减少聚集和细胞毒性。
Macromol Biosci. 2010 Oct 8;10(10):1152-63. doi: 10.1002/mabi.200900448.
9
Polyoxometalates as inhibitors of the aggregation of amyloid β peptides associated with Alzheimer's disease.多金属氧酸盐作为与阿尔茨海默病相关的淀粉样β肽聚集的抑制剂。
Angew Chem Int Ed Engl. 2011 Apr 26;50(18):4184-8. doi: 10.1002/anie.201007067. Epub 2011 Mar 23.
10
Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.阿尔茨海默病淀粉样 β-蛋白突变和缺失,定义了神经元结合/内化作为早期非纤维/纤维状聚集物和晚期纤维的阶段。
Biochemistry. 2012 May 15;51(19):3993-4003. doi: 10.1021/bi300275g. Epub 2012 May 7.

引用本文的文献

1
Nanoplatforms Targeting Intrinsically Disordered Protein Aggregation for Translational Neuroscience Applications.用于转化神经科学应用的靶向内在无序蛋白聚集的纳米平台。
Nanomaterials (Basel). 2025 May 8;15(10):704. doi: 10.3390/nano15100704.
2
Polyoxometalates bind multiple targets involved in Alzheimer's disease.多金属氧酸盐与阿尔茨海默病涉及的多个靶点结合。
J Biol Inorg Chem. 2025 Apr;30(3):299-309. doi: 10.1007/s00775-025-02111-2. Epub 2025 Mar 22.
3
Nanoscale drug formulations for the treatment of Alzheimer's disease progression.
用于治疗阿尔茨海默病进展的纳米级药物制剂。
RSC Adv. 2025 Feb 7;15(6):4031-4078. doi: 10.1039/d4ra08128e. eCollection 2025 Feb 6.
4
Peptide-based amyloid-beta aggregation inhibitors.基于肽的β-淀粉样蛋白聚集抑制剂。
RSC Med Chem. 2024 Dec 31. doi: 10.1039/d4md00729h.
5
Polyoxometalates: metallodrug agents for combating amyloid aggregation.多金属氧酸盐:用于对抗淀粉样蛋白聚集的金属药物制剂。
Natl Sci Rev. 2024 Jun 28;11(7):nwae226. doi: 10.1093/nsr/nwae226. eCollection 2024 Jul.
6
Novel fabrication of Cu(II)-incorporated chiral d-penicillamine-chitosan nanocomposites enantio-selectively inhibit the induced amyloid β aggregation for Alzheimer's disease therapy.新型制备的含铜(II)手性d-青霉胺-壳聚糖纳米复合材料对阿尔茨海默病治疗中诱导的淀粉样β蛋白聚集具有对映选择性抑制作用。
Heliyon. 2023 Dec 11;10(1):e23563. doi: 10.1016/j.heliyon.2023.e23563. eCollection 2024 Jan 15.
7
Advancements in the Application of Nanomedicine in Alzheimer's Disease: A Therapeutic Perspective.纳米医学在阿尔茨海默病中的应用进展:治疗视角。
Int J Mol Sci. 2023 Sep 13;24(18):14044. doi: 10.3390/ijms241814044.
8
Impact of nanoparticles on amyloid β-induced Alzheimer's disease, tuberculosis, leprosy and cancer: a systematic review.纳米颗粒对淀粉样蛋白β诱导的阿尔茨海默病、结核病、麻风病和癌症的影响:系统评价。
Biosci Rep. 2023 Feb 27;43(2). doi: 10.1042/BSR20220324.
9
Advanced nanomaterials for modulating Alzheimer's related amyloid aggregation.用于调节阿尔茨海默病相关淀粉样蛋白聚集的先进纳米材料。
Nanoscale Adv. 2022 Nov 21;5(1):46-80. doi: 10.1039/d2na00625a. eCollection 2022 Dec 20.
10
Polyoxometalate-peptide hybrid materials: from structure-property relationships to applications.多金属氧酸盐-肽杂化材料:从结构-性能关系到应用
Chem Sci. 2022 Nov 16;14(1):10-28. doi: 10.1039/d2sc05105b. eCollection 2022 Dec 21.